30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

SI-BONE Closes $20MM Round of Growth Financing -

SI-BONE closed a US $20MM round of growth capital financing, led by new investor Arboretum Ventures with participation from all of SI-BONE's existing major investors. 

Proceeds will support expansion of U.S. sales, following recent decisions to cover MIS SI joint fusion by Blue Cross Blue Shield of Michigan, Geisinger Health Plan in Pennsylvania and First Coast Service Options in Florida.  Additional proceeds will support R&D to develop new products to treat the SI joint.

SI-BONE's last funding announcement occurred in 4Q15, with the closing of a $39.2MM credit facility .

Sources: SI-BONE, Inc.; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.